Portfolio (Quarterly)
Guide ↗
Duquesne Family Office LLC
· CIK 0001536411| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | ENTG | Entegris Inc | Technology | 118,300.0 | $21.3M | 0.41% | NEW | — | $179.86 | -22.5% |
| 22 | AEVA | Aeva Technologies Inc | Consumer Cyclical | 720,175.0 | $20.7M | 0.40% | NEW | — | $28.72 | -43.7% |
| 23 | RIOT | Riot Platforms Inc | Financial Services | 754,800.0 | $20.7M | 0.40% | NEW | — | $27.38 | -22.5% |
| 24 | EQIX | Equinix Inc | Real Estate | 18,450.0 | $19.2M | 0.37% | NEW | — | $1042.38 | +3.0% |
| 25 | LRCX | Lam Research Corp | Technology | 43,600.0 | $18.9M | 0.36% | NEW | — | $433.33 | -27.9% |
| 26 | DFTX | Definium Therapeutics Inc | Healthcare | 356,600.0 | $16.8M | 0.32% | NEW | — | $47.04 | -4.2% |
| 27 | RSP | Invesco Exchange Traded Fd T | — | 74,400.0 | $15.8M | 0.30% | NEW | — | $212.77 | +4.2% |
| 28 | TXG | 10X Genomics Inc | Healthcare | 403,100.0 | $15.5M | 0.30% | NEW | — | $38.34 | +70.6% |
| 29 | LLY | Eli Lilly & Co | Healthcare | 12,380.0 | $14.8M | 0.28% | NEW | — | $1199.43 | +3.9% |
| 30 | RGEN | Repligen Corp | Healthcare | 77,400.0 | $10.6M | 0.20% | NEW | — | $136.43 | +33.2% |
| 31 | RKT | Rocket Cos Inc | Financial Services | 652,220.0 | $10.3M | 0.20% | NEW | — | $15.75 | -10.3% |
| 32 | BIDU | Baidu Inc | Communication Services | 88,200.0 | $10.1M | 0.19% | NEW | — | $114.29 | -18.9% |
| 33 | CVNA | Carvana Co | Consumer Cyclical | 151,000.0 | $9.9M | 0.19% | NEW | — | $65.82 | +16.0% |
| 34 | RDDT | Reddit Inc | Communication Services | 56,550.0 | $9.8M | 0.19% | NEW | — | $173.58 | -7.7% |
| 35 | TMO | Thermo Fisher Scientific Inc | Healthcare | 19,200.0 | $9.6M | 0.18% | NEW | — | $501.35 | +25.1% |
| 36 | DHR | Danaher Corp Del | Healthcare | 50,300.0 | $9.6M | 0.18% | NEW | — | $190.48 | +13.1% |
| 37 | FFIV | F5 Inc | Technology | 22,000.0 | $9.2M | 0.18% | NEW | — | $415.95 | -8.7% |
| 38 | — | Skeena Res Ltd New | — | 300,200.0 | $8.0M | 0.15% | NEW | — | $26.66 | — |
| 39 | GLUE | Monte Rosa Therapeutics Inc | Healthcare | 297,600.0 | $7.2M | 0.14% | NEW | — | $24.20 | -39.6% |
| 40 | RLAY | Relay Therapeutics Inc | Healthcare | 349,000.0 | $6.5M | 0.12% | NEW | — | $18.71 | +10.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.3%
Technology
29.5%
Consumer Cyclical
10.7%
Communication Services
7.4%
Industrials
7.4%
Energy
4.0%
Basic Materials
3.2%
Financial Services
1.1%
Real Estate
0.5%